Vcanbio Cell & Gene Engineering Corp., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: SHG:600645
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 360 out of 850
Universe
Global Universe 9275 out of 15080
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Xencor, Inc. |
23.6
Medium
|
153 out of 850 |
Intellia Therapeutics, Inc. |
26.9
Medium
|
302 out of 850 |
Vcanbio Cell & Gene Engineering Corp., Ltd. |
27.6
Medium
|
360 out of 850 |
Ardelyx, Inc. |
28.9
Medium
|
433 out of 850 |
Arcus Biosciences, Inc. |
32.1
High
|
569 out of 850 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Vcanbio Cell & Gene Engineering Corp., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Vcanbio Cell & Gene Engineering Corp., Ltd.'s Management of ESG Material Risk is Average